Observational studyFrontiers in immunology2022

Safety and Immunogenicity of Inactivated and Recombinant Protein SARS-CoV-2 Vaccines in Patients With Thyroid Cancer.

Yuling Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.